Key result
Concomitant hypertension and proteinuria linked to ~8-fold higher progression risk in pediatric CKD stages 3-4.
Why the study?
Whether the coexistence of hypertension and proteinuria produces a multiplicative interaction in pediatric CKD progression remains uncertain.
Does the coexistence of hypertension and proteinuria produce a multiplicative interaction that accelerates CKD progression in children?
Cohort (n=254)
Yes
Does the coexistence of hypertension and proteinuria produce a multiplicative interaction that accelerates CKD progression in children?
Hypertension and proteinuria are strong independent predictors of CKD progression in children, and their coexistence confers an 8.4-fold increased risk, though a multiplicative interaction could not be statistically confirmed due to limited power.
Answers are grounded in this paper and cite their sources.
May inform risk stratification in pediatric CKD stages 3-4; leaves open whether hypertension-proteinuria interaction is multiplicative and requires prospective validation.
BACKGROUND: Hypertension and proteinuria are established risk factors for chronic kidney disease (CKD) progression in children. Given their pathophysiological interrelationship, whether their coexistence produces a multiplicative interaction remains uncertain. We evaluated this interaction in a Brazilian pediatric cohort. METHODS: This multicenter prospective cohort (SP-CKD-Kids) included 254 children and adolescents aged 1-17 years at study entry with CKD stages 3-4, followed for a median of 3.2 years. The composite outcome comprised death, initiation of kidney replacement therapy, or > 50% decline in estimated glomerular filtration rate (eGFR). Cox models were adjusted for age, sex, baseline eGFR, and CKD etiology. Multiplicative interaction was assessed using a hypertension × proteinuria product term, and statistical power was evaluated by simulation. RESULTS: Hypertension was present in 67.3% of participants and proteinuria in 77.1%; 98 participants (38.6%) experienced the composite outcome. After adjustment, hypertension (hazard ratio [HR] 1.7; 95% confidence interval [CI] 1.0-2.8) and proteinuria (HR 3.5; 95% CI 1.7-7.0) remained independently associated with CKD progression. Participants with both conditions had the highest risk compared with those with neither condition (HR 8.4; 95% CI 2.1-34.2). The multiplicative interaction was not statistically significant (HR 0.6; 95% CI 0.1-3.0; p = 0.507), and simulation indicated limited power to detect interaction effects. CONCLUSIONS: Hypertension and proteinuria were independent predictors of CKD progression in children. Although no statistically significant multiplicative interaction was detected, the wide confidence interval around the interaction term indicates that a clinically relevant interaction cannot be excluded.
No takes yet. Share an insight, caveat, or question.
Machado et al. (2026) conducted a cohort in Chronic kidney disease (CKD) stages 3-4 (n=254). Concomitant hypertension and proteinuria vs. Neither condition was evaluated on Composite of death, initiation of kidney replacement therapy, or >50% decline in estimated GFR (multiplicative interaction) (HR 0.6, 95% CI 0.1-3.0, p=0.507). In children with CKD stages 3-4, concomitant hypertension and proteinuria markedly increased the risk of disease progression, though no significant multiplicative interaction was detected.
Synapse has enriched 10 related papers. Consider them for comparative context: